{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06294236",
            "orgStudyIdInfo": {
                "id": "SC291-102"
            },
            "organization": {
                "fullName": "Sana Biotechnology",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)",
            "officialTitle": "A Phase 1 Study Evaluating SC291, a Hypoimmune, Allogeneic CD19-directed CAR T Cell Therapy, in Subjects With Severe Relapsed or Refractory Autoimmune Diseases (GLEAM)",
            "therapeuticArea": [
                "Immunology and Rheumatology",
                "Other"
            ],
            "study": "study-evaluating-in-subjects-with-severe-r-r-b-cell-mediated-autoimmune-diseases-gleam"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-12",
            "studyFirstSubmitQcDate": "2024-02-27",
            "studyFirstPostDateStruct": {
                "date": "2024-03-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sana Biotechnology",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "SC291-102 is a Phase 1 study to assess SC291 safety and tolerability, preliminary clinical response, cellular kinetics and exploratory assessments for subjects with severe autoimmune diseases.",
            "detailedDescription": "Systemic lupus erythematosus (SLE) is an autoimmune disease with multisystemic organ involvement that is often fatal. SLE is subcategorized as extrarenal lupus (ERL) or lupus nephritis (LN). B cell depletion therapies have played an important role in the treatment of multiple B cell-driven autoimmune diseases.\n\nSubjects included in this trial will be subjects with diagnoses of systemic lupus erythematosus (SLE) including lupus nephritis (LN) and extrarenal systemic lupus erythematosus (ERL), or anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) (including Granulomatous Polyangitis and Microscopic Polyangiitis) who have refractory disease, have relapsed and have not shown appropriate clinical responses following prior systemic treatments.\n\nThis study is being conducted to assess the safety and efficacy of an investigational cell therapy, SC291, that can be given to patients with LN, ERL or AAV, in separate parallel cohorts, who have active disease.\n\nA single dose of SC291 will be assessd in patients who are pretreated with a standard regimen including cyclophosphamide (CY) and fludarabine (FLU)."
        },
        "conditionsModule": {
            "conditions": [
                "Lupus Erythematosus",
                "Systemic Lupus Erythematosus",
                "SLE (Systemic Lupus)",
                "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis",
                "Granulomatous Polyangiitis",
                "Microscopic Polyangiitis"
            ],
            "keywords": [
                "Autoimmune Disease",
                "Systemic Lupus Erythematosus",
                "Lupus Nephritis",
                "Lupus",
                "Extrarenal Lupus",
                "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis",
                "Granulomatous Polyangitis",
                "Microscopic Polyangiitis",
                "CAR T Cell Therapy",
                "Allogeneic",
                "Hypoimmune",
                "CD19",
                "Cyclophosphamide",
                "Fludarabine",
                "Cellular Therapy",
                "SC291",
                "ANCA Associated Vasculitis",
                "SLE",
                "ANCA",
                "Vasculitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LN Cohort",
                    "type": "EXPERIMENTAL",
                    "description": "SC291 with lymphodepleting therapy",
                    "interventionNames": [
                        "Biological: SC291"
                    ]
                },
                {
                    "label": "ERL Cohort",
                    "type": "EXPERIMENTAL",
                    "description": "SC291 with lymphodepleting therapy",
                    "interventionNames": [
                        "Biological: SC291"
                    ]
                },
                {
                    "label": "AAV Cohort",
                    "type": "EXPERIMENTAL",
                    "description": "SC291 with lymphodepleting therapy",
                    "interventionNames": [
                        "Biological: SC291"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "SC291",
                    "description": "SC291 is an allogeneic CAR T cell therapy",
                    "armGroupLabels": [
                        "AAV Cohort",
                        "ERL Cohort",
                        "LN Cohort"
                    ],
                    "otherNames": [
                        "Cyclophosphamide",
                        "Fludarabine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Evaluate safety and tolerability of SC291",
                    "description": "Safety and Tolerability: Proportion of subjects experiencing adverse events and dose-limiting toxicities",
                    "timeFrame": "24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Evaluate preliminary clinical response to SC291",
                    "description": "Change from baseline in renal function as measured by Estimated Glomerular Filtration Rate (eGFR) (calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation)",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291",
                    "description": "Change from baseline in proteinuria as measured by Urine Protein Creatinine Ratio (UPCR)",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291",
                    "description": "Duration of drug free remission",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291",
                    "description": "Time to relapse",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291 (LN and ERL Cohorts)",
                    "description": "Change from baseline of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291 (LN Cohort)",
                    "description": "Change in disease activity as measured by proportion of subjects achieving complete renal response or partial renal response",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291 (ERL Cohort)",
                    "description": "Change in disease activity as measured by proportion of subjects achieving modified Definitions Of Remission In Systemic Lupus Erythematosus (DORIS) remission",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291 (AAV Cohort)",
                    "description": "Change in disease activity as measured by proportion of subjects achieving remission (Birmingham Vasculitis Activity Score version 3 \\[BVAS v3\\] of 0)",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate preliminary clinical response to SC291 (AAV Cohort)",
                    "description": "Change in disease activity as measured by change from baseline in BVAS v3",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Evaluate cellular kinetics and persistence of SC291",
                    "description": "Levels of SC291 CAR+ T cells in the blood",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \u226518 and \u226475\n2. For LN cohort:\n\n   * Diagnosis of SLE based on the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR)\n   * Biopsy-proven LN class III or IV, according to 2018 Revised International Society of Nephrology/Renal Pathology Society (ISN/RPS) criteria\n   * Refractory disease to \u2265 2 prior treatment regimens\n3. For ERL cohort:\n\n   * Diagnosis of SLE based on the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for adult SLE\n   * Severe or relapsing disease not responding to at least 2 prior recent disease-modifying therapies\n4. For AAV Cohort, diagnosed with Granulomatous Polyangiitis (GPA) or Microscopic Polyangiitis (MPA) based on the 2022 ACR/EULAR classification criteria\n\nExclusion Criteria:\n\n1. Prior CD19-directed cell therapy including CAR T treatment or other genetically modified cell therapy (e.g., Natural Killer (NK) cell)\n2. For LN and ERL Cohorts, central nervous system (CNS) lupus manifestations or history or presence of CNS disorder\n3. For LN and ERL Cohorts, diagnosis of anti-phospholipid antibody syndrome\n4. For AAV Cohort only, Diagnosis of Eosinophilic Granulomatosis with Polyangiitis (EGPA) as defined by the 2022 ACR/EULAR classification criteria for EGPA -",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sana Biotechnology, Inc",
                    "role": "CONTACT",
                    "phone": "(206) 707-9904",
                    "email": "Gleam@sana.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Paul Brunetta",
                    "affiliation": "Sana Biotechnology, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Wagner",
                            "role": "CONTACT",
                            "phone": "303-724-7790"
                        },
                        {
                            "name": "Amber Podoll",
                            "role": "CONTACT",
                            "phone": "303-724-7790"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Johns Hopkins Hospital",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maximilian Konig, MD",
                            "role": "CONTACT",
                            "email": "konig@jhmi.edu"
                        },
                        {
                            "name": "Liana Boccio",
                            "role": "CONTACT",
                            "email": "lboccio1@jhmi.edu"
                        },
                        {
                            "name": "Maximilian Konig, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Guy Katz, MD",
                            "role": "CONTACT",
                            "phone": "617-726-7938"
                        },
                        {
                            "name": "Guy Katz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Swedish Medical Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98122",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Richie Satira, RN",
                            "role": "CONTACT",
                            "phone": "206-386-2000",
                            "email": "richard.satira@swedish.org"
                        },
                        {
                            "name": "Danna Caceres-Reyes, RN",
                            "role": "CONTACT",
                            "phone": "206-386-2000",
                            "email": "Danna.Caceres-Reyes@swedish.org"
                        },
                        {
                            "name": "Philip J. Mease, MD, MACR",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014890",
                    "term": "Granulomatosis with Polyangiitis"
                },
                {
                    "id": "D000055953",
                    "term": "Microscopic Polyangiitis"
                },
                {
                    "id": "D000014657",
                    "term": "Vasculitis"
                },
                {
                    "id": "D000056647",
                    "term": "Systemic Vasculitis"
                },
                {
                    "id": "D000056648",
                    "term": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis"
                },
                {
                    "id": "D000008180",
                    "term": "Lupus Erythematosus, Systemic"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000059345",
                    "term": "Cerebral Small Vessel Diseases"
                },
                {
                    "id": "D000002561",
                    "term": "Cerebrovascular Disorders"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000017445",
                    "term": "Skin Diseases, Vascular"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000017563",
                    "term": "Lung Diseases, Interstitial"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12338",
                    "name": "Nephritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M11178",
                    "name": "Lupus Nephritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M11177",
                    "name": "Lupus Erythematosus, Systemic",
                    "asFound": "Systemic Lupus Erythematosus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "asFound": "Autoimmune Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17630",
                    "name": "Granulomatosis with Polyangiitis",
                    "asFound": "Granulomatous Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17405",
                    "name": "Vasculitis",
                    "asFound": "Vasculitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28527",
                    "name": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis",
                    "asFound": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28400",
                    "name": "Microscopic Polyangiitis",
                    "asFound": "Microscopic Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28526",
                    "name": "Systemic Vasculitis",
                    "asFound": "Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M29437",
                    "name": "Cerebral Small Vessel Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5810",
                    "name": "Cerebrovascular Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19714",
                    "name": "Skin Diseases, Vascular",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19813",
                    "name": "Lung Diseases, Interstitial",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3523",
                    "name": "Lupus Nephritis",
                    "relevance": "LOW"
                },
                {
                    "id": "T2610",
                    "name": "Granulomatosis With Polyangiitis",
                    "asFound": "Granulomatous Polyangiitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T375",
                    "name": "ANCA-associated Vasculitis",
                    "asFound": "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3807",
                    "name": "Microscopic Polyangiitis",
                    "asFound": "Microscopic Polyangiitis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "C000024352",
                    "term": "Fludarabine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "asFound": "Rate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}